[Wilson's disease. II].
D000293:Adolescent; D001847:Bone Diseases / Q000209:etiology; D002570:Ceruloplasmin / Q000032:analysis; D002648:Child; D003300:Copper / Q000032:analysis; D005128:Eye Diseases / Q000209:etiology; D005260:Female; D006402:Hematologic Diseases / Q000209:etiology; D006527:Hepatolenticular Degeneration / Q000150:complications / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D006579:Heterozygote; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology; D008107:Liver Diseases / Q000209:etiology; D008297:Male; D009422:Nervous System Diseases / Q000209:etiology; D010396:Penicillamine / Q000627:therapeutic use; D011379:Prognosis; D011868:Radioisotopes
D011868:Radioisotopes; D003300:Copper; D002570:Ceruloplasmin; D010396:Penicillamine
Enfermedad de Wilson. Parte segunda.